---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-078287"
form_type: "8-K"
ticker: "CTOR"
cik: "0001851484"
company_name: "CITIUS ONCOLOGY, INC."
filed_at: "2024-09-13T23:59:59+00:00"
generated_at: "2026-05-31T05:01:38.582518+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Citius Oncology secures partial deferral of milestone payment to Dr. Reddy's without penalty

## Summary
- Milestone payment triggered by FDA approval of LYMPHIR was due Sept 9, 2024; partial deferral granted without penalty.
- All other terms and conditions of the Asset Purchase Agreement remain in full force and effect.
- Further discussions with Dr. Reddy's pending; partial deferral avoids immediate cash outflow.

## SEC filing metadata
- accession: 0001213900-24-078287
- form_type: 8-K
- ticker: CTOR
- cik: 0001851484
- company_name: CITIUS ONCOLOGY, INC.
- filed_at: 2024-09-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1851484/000121390024078287/0001213900-24-078287-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1851484/000121390024078287/ea0214419-8k_citius.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-078287
- JSON: https://secwatch.observer/filing/0001213900-24-078287.json
- Plain text: https://secwatch.observer/filing/0001213900-24-078287.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.